Top compounds associated with response to FRA10AC1


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC 0.083 0.02
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.02
mRNA linifanib CTRPv2 pan-cancer AAC 0.081 0.02
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.08 0.02
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.082 0.02
mRNA Bortezomib GDSC1000 pan-cancer AAC -0.11 0.03
mRNA ouabain CTRPv2 pan-cancer AAC 0.077 0.03
mRNA FH535 GDSC1000 pan-cancer AAC 0.076 0.03
mRNA myriocin CTRPv2 pan-cancer AAC -0.17 0.03
mRNA CGP-60474 GDSC1000 pan-cancer AAC -0.11 0.03
Download CSV